PMA device
Axonics Sacral Neuromodulation System
Boston Scientific Corporation · Stimulator, Electrical, Implantable, For Incontinence (EZW, Class III) · First FDA decision Nov 13, 2019, newest Aug 7, 2026Fecal incontinence and constipationOveractive bladder and urinary incontinence
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
22
PMA pathway
Device trials
5
Naming "Axonics Sacral Neuromodulation"
MAUDE reports
11
Brand "Axonics Sacral Neuromodulation", since 2015
PubMed studies
0
Mentioning "Axonics Sacral Neuromodulation"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Axonics Sacral Neuromodulation System
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology, with pictures of the device
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 6 of 22 decisions filed under this name.
- Axonics Sacral Neuromodulation SystemPMA supplement
P180046-S113 · Decided Aug 7, 2026 · 56 days after receipt · Normal 180 Day Track
Device type: Stimulator, electrical, implantable, for incontinence (EZW) · GI, Urology & Nephrology
5 more FDA decisions with a free account
Older decisions: P180046-S079, P180046-S078, P180046-S076, P180046-S071, P180046-S066, P180046-S063, P180046-S062, P180046-S061, P180046-S056, P180046-S054, P180046-S038, P180046-S025, P180046-S024, P180046-S015, P180046-S011, P180046
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- Non-Implantable Pelvic Floor Electrical StimulatorNational determinationOn the books230.8Updated Aug 17, 2023
- Pelvic Floor Electrical Stimulation for Urinary IncontinenceNational analysisReview closedCAG-00021NUpdated Sep 15, 2026
- Transcutaneous Electrical Nerve Stimulators (TENS) - RETIREDNational determinationOn the books280.13Updated Jun 7, 2024
- Electrical Nerve StimulatorsNational determinationOn the books160.7Updated Aug 17, 2023
- Transcutaneous Electrical Nerve Stimulators (TENS)Local determinationIn effectL33802CGS Administrators, LLCUpdated Dec 7, 2023
Clinical trials
Device studies on ClinicalTrials.gov that name "Axonics Sacral Neuromodulation", any status and sponsor, newest update first.
Axonics, Inc.Not on our public-company list
NCT07335484 · 75 participants (planned) · Start Apr 30, 2026 · Primary completion Nov 2026
Device: Axonics External Trial System (ETS) · For: Urinary Urge Incontinence (UUI); Urinary Frequency (UF); Fecal Incontinence (FI) and 1 more
Sites: Birmingham, Alabama; Macon, Georgia; Chicago, Illinois · 6 sites in all
4 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Axonics Sacral Neuromodulation", and for the whole product code for context.
This brand
11 reports: 3 malfunction, 5 injury, 0 death
Whole product code EZW
68,097 reports: 34,391 malfunction, 33,649 injury, 34 death
Newest reports for this brand
MW6004166 · Received Oct 19, 2026
Device type: Stimulator, Electrical, Implantable, For Incontinence (EZW)
Device problem as coded: Connection Problem
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
4 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
- PNE Lead Implant Kit REF: 1701Open, Classified
Z-0198-2027 · Started Jul 15, 2024 · Posted by FDA Oct 16, 2026
Reason given: Retroactively Reported: 10mL luer lock syringes included in kit may leak , break or experience other issues that may pose a risk to users.
Cause as FDA categorized it: Component change control · Device type: Stimulator, Electrical, Implantable, For Incontinence (EZW)
Published research
The most relevant PubMed records for "Axonics Sacral Neuromodulation"[tiab]. The summary above synthesizes these.
No PubMed record mentions this device by name.
Other devices of this type
Also filed under product code EZW.
- InterStim Therapy System, Verify Evaluation SystemMedtronic Neuromodulation · PMA 2025
- InterStim® Sacral Nerve Stimulation Therapy System (Urinary Control )Medtronic Neuromodulation · PMA 2018
- Neuspera Sacral Neuromodulation (SNM) SystemNeuspera Medical, Inc. · PMA 2026
- Master InterStim® Therapy System, Verify® Evaluation SystemMedtronic Neuromodulation · PMA 2022
- Interstim SystemMedtronic Neuromodulation · PMA 2011
- Medtronic Interstim Tined Lead Models 3889 & 3093Medtronic Neuromodulation · PMA 2007
- Virtis Sacral Neuromodulation SystemCirtec Medical Corporation · PMA 2023
- Verify Evaluation System for Interstim Therapy for Urinary Control and Bowel ControlMedtronic Neuromodulation · PMA 2015
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.